Artwork

Indhold leveret af David Hunter and FRACP (Rheum). Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af David Hunter and FRACP (Rheum) eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

The journey of a disease-modifying osteoarthritis drug: From research to reality

37:57
 
Del
 

Manage episode 440074092 series 3244565
Indhold leveret af David Hunter and FRACP (Rheum). Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af David Hunter and FRACP (Rheum) eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In this week's episode, we explore the quest for a therapy that not only alleviates symptoms of osteoarthritis but also addresses the underlying disease process. Host Professor David Hunter is joined by Chris Knight and Dr Sandeep Basnet from Formation Bio to discuss the complexities and breakthroughs in developing disease-modifying osteoarthritis drugs (DMOADs).

They dive into the challenges of clinical trials, the high stakes of drug development, and the promising future of AI in revolutionising this field.

Tune in to learn how close we are to seeing these game-changing therapies become a reality and what it could mean for millions living with osteoarthritis.

RESOURCES

Formation Bio: https://www.formation.bio/

CONNECT WITH US



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

128 episoder

Artwork
iconDel
 
Manage episode 440074092 series 3244565
Indhold leveret af David Hunter and FRACP (Rheum). Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af David Hunter and FRACP (Rheum) eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In this week's episode, we explore the quest for a therapy that not only alleviates symptoms of osteoarthritis but also addresses the underlying disease process. Host Professor David Hunter is joined by Chris Knight and Dr Sandeep Basnet from Formation Bio to discuss the complexities and breakthroughs in developing disease-modifying osteoarthritis drugs (DMOADs).

They dive into the challenges of clinical trials, the high stakes of drug development, and the promising future of AI in revolutionising this field.

Tune in to learn how close we are to seeing these game-changing therapies become a reality and what it could mean for millions living with osteoarthritis.

RESOURCES

Formation Bio: https://www.formation.bio/

CONNECT WITH US



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

128 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning